Lilly Brings Biotech to Indy

Three years ago, Eli Lilly & Co. unveiled plans to invest $1 billion in capital improvements and create 7,500 new jobs in Marion County within a decade -- one of the largest economic development endeavors in Indiana's history. Now the company announced that Lilly has already exceeded its capital commitment by investing over $1.1 billion in Marion County to construct new facilities supporting research and development, manufacturing, biotechnology and general administration. Additionally, the company announced two new capital projects that are part of its overall global capital investment plan. The first will be a $225 million biotech research and product development facility in Indianapolis. The second will be a $425 million insulin manufacturing facility in Virginia. The investments for these two projects will be made over the course of the next five years.